![Ross Moat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ross Moat
Keine laufenden Positionen mehr
Vermögen: 581 963 $ am 31.05.2026
Profil
Ross Moat currently works at Kiniksa Pharmaceuticals Ltd. as Chief Commercial Officer & Senior Vice President since 2022.
Mr. Moat also works at Kiniksa Pharmaceuticals International Plc as Chief Operating Officer & Executive Vice President starting in 2026.
Former roles include General Manager at Synageva BioPharma Corp.
and VP-EMEA Marketing & Commercial Operations at Novartis Gene Therapies, Inc. from 2018 to 2019.
Education includes an undergraduate degree from Middlesex University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,03 % | 09.04.2026 | 12.029 ( 0,03 % ) | 581 963 $ | 31.05.2026 |
Aktive Positionen von Ross Moat
| Unternehmen | Position | Beginn |
|---|---|---|
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Corporate Officer/Principal | 01.02.2021 |
Ehemalige bekannte Positionen von Ross Moat
| Unternehmen | Position | Ende |
|---|---|---|
| AVEXIS INC | Vertrieb & Marketing | 01.06.2019 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | - |
Ausbildung von Ross Moat
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Middlesex University
 Middlesex University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
